424 related articles for article (PubMed ID: 19535565)
1. Attention deficit hyperactivity disorder in prison.
Ghanizadeh A; Akhondzadeh S
J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
[No Abstract] [Full Text] [Related]
2. Attention deficit hyperactivity disorder in prison: a treatment protocol.
Appelbaum KL
J Am Acad Psychiatry Law; 2009; 37(1):45-9. PubMed ID: 19297632
[TBL] [Abstract][Full Text] [Related]
3. The top ten reasons to limit prescription of controlled substances in prisons.
Burns KA
J Am Acad Psychiatry Law; 2009; 37(1):50-2. PubMed ID: 19297633
[TBL] [Abstract][Full Text] [Related]
4. The answerable question and a hierarchy of evidence.
Hamilton J
J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):596-600. PubMed ID: 15908843
[No Abstract] [Full Text] [Related]
5. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
6. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
Faraone SV; Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
[TBL] [Abstract][Full Text] [Related]
7. Atomoxetine and nonresponders to stimulants.
Velcea G; Winsberg BG
Am J Psychiatry; 2004 Sep; 161(9):1718-9. PubMed ID: 15337674
[No Abstract] [Full Text] [Related]
8. Improving decision making in the treatment of ADHD.
Vitiello B
Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
[No Abstract] [Full Text] [Related]
9. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
10. [Without treatment the crash threatens].
Einecke U
MMW Fortschr Med; 2009 Jan; 151(5):14-6. PubMed ID: 19391404
[No Abstract] [Full Text] [Related]
11. Attention-deficit hyperactivity disorder diagnosis and treatment. Separating myth from substance.
Barzman DH; Fieler L; Sallee FR
J Leg Med; 2004 Mar; 25(1):23-38. PubMed ID: 15208788
[No Abstract] [Full Text] [Related]
12. Drugs for treatment of ADHD.
Treat Guidel Med Lett; 2011 May; 9(105):23-8; quiz 2 p following 28. PubMed ID: 21519317
[No Abstract] [Full Text] [Related]
13. Attention-Deficit Hyperactivity Disorder.
DuPont RL
Essent Psychopharmacol; 2005; 6(5):iv. PubMed ID: 16222908
[No Abstract] [Full Text] [Related]
14. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
Strawn MN
J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
[No Abstract] [Full Text] [Related]
15. New Ritalin ad blitz makes parents jumpy.
Novak V
Time; 2001 Sep; 158(10):62-3. PubMed ID: 11558351
[No Abstract] [Full Text] [Related]
16. Hyperactivity really IS common...and a new warning about treatment.
Child Health Alert; 2005 Nov; 23():3. PubMed ID: 16416539
[No Abstract] [Full Text] [Related]
17. Drugs for treatment of ADHD.
Treat Guidel Med Lett; 2006 Nov; 4(51):77-82. PubMed ID: 17039210
[No Abstract] [Full Text] [Related]
18. [The practice and problem of therapeutic agents for AD/HD].
Tanaka H; Miyajima T
No To Hattatsu; 2010 May; 42(3):213-6. PubMed ID: 23858580
[No Abstract] [Full Text] [Related]
19. What exactly are the benefits of stimulants for ADHD?
Advokat C
J Atten Disord; 2009 May; 12(6):495-8. PubMed ID: 19380518
[No Abstract] [Full Text] [Related]
20. Who is using the drugs I prescribe?
Winkelaar PG
Can Fam Physician; 2002 May; 48():883. PubMed ID: 12053632
[No Abstract] [Full Text] [Related]
[Next] [New Search]
